0
Advanced Search
Journal Articles about Antipsychotics Showing 161-180 of 1315
Psychiatric Services >
Columns | December 01, 2006
Antipsychotic Use and Expenditure in the United States
Rajender R. Aparasu, Ph.D.; Vinod Bhatara, M.D., M.S.
Psychiatric Services. 2006 December ; 12(57):1693-1693
PDFPDF
The American Journal of Psychiatry >
Reviews and Overviews | December 01, 2006
Clinical Trial-Based Cost-Effectiveness Analyses of Antipsychotic Use
Daniel Polsky, Ph.D.; Jalpa A. Doshi, Ph.D.; Mark S. Bauer, M.D.; Henry A. Glick, Ph.D.
The American Journal of Psychiatry. 2006 December ; 12(163):2047-2056
PDFPDF
The American Journal of Psychiatry >
Article | December 01, 2006
A Randomized, Double-Blind, Placebo-Controlled Trial of Metformin Treatment of Weight Gain Associated With Initiation of Atypical Antipsychotic Therapy in Children and Adolescents
David J. Klein, M.D., Ph.D.; Elizabeth M. Cottingham, M.D.; Michael Sorter, M.D.; Bruce A. Barton, Ph.D.; John A. Morrison, Ph.D.
The American Journal of Psychiatry. 2006 December ; 12(163):2072-2079
PDFPDF
The American Journal of Psychiatry >
Article | December 01, 2006
Cost-Effectiveness of Second-Generation Antipsychotics and Perphenazine in a Randomized Trial of Treatment for Chronic Schizophrenia
Robert A. Rosenheck, M.D.; Douglas L. Leslie, Ph.D.; Jody Sindelar, Ph.D.; Edward A. Miller, Ph.D.; Haiqun Lin, Ph.D.; T. Scott Stroup, M.D., M.P.H.; Joseph McEvoy, M.D.; Sonia M. Davis, Dr.P.H.; Richard S.E. Keefe, Ph.D.; Marvin Swartz, M.D.; Diana O. Perkins, M.D., M.P.H.; John K. Hsiao, M.D.; Jeffrey Lieberman, M.D., for the CATIE Study Investigators
The American Journal of Psychiatry. 2006 December ; 12(163):2080-2089
PDFPDF  |    Data Supplements
The American Journal of Psychiatry >
Article | December 01, 2006
Effectiveness of Switching Antipsychotic Medications
Susan M. Essock, Ph.D.; Nancy H. Covell, Ph.D.; Sonia M. Davis, Dr.P.H.; T. Scott Stroup, M.D.; Robert A. Rosenheck, M.D.; Jeffrey A. Lieberman, M.D.
The American Journal of Psychiatry. 2006 December ; 12(163):2090-2095
PDFPDF  |    Data Supplements
The American Journal of Psychiatry >
Article | December 01, 2006
Randomized Comparison of Olanzapine Versus Risperidone for the Treatment of First-Episode Schizophrenia: 4-Month Outcomes
Delbert G. Robinson, M.D.; Margaret G. Woerner, Ph.D.; Barbara Napolitano, M.A.; Raman C. Patel, M.D.; Serge M. Sevy, M.D., M.B.A.; Handan Gunduz-Bruce, M.D.; Jose M. Soto-Perello, M.D.; Alan Mendelowitz, M.D.; Ali Khadivi, Ph.D.; Rachel Miller, L.C.S.W.; Joanne McCormack, L.C.S.W.; Beth S. Lorell, L.C.S.W.; Martin L. Lesser, Ph.D.; Nina R. Schooler, Ph.D.; John M. Kane, M.D.
The American Journal of Psychiatry. 2006 December ; 12(163):2096-2102
PDFPDF  |  CME Activity (3)  |    Data Supplements
The American Journal of Psychiatry >
Brief Report | November 01, 2006
Reduced Thalamic Volume in Patients With Chronic Schizophrenia After Switching From Typical Antipsychotic Medications to Olanzapine
Babak Khorram, B.Sc.; Donna J. Lang, Ph.D.; Lili C. Kopala, M.D., F.R.C.P.C.; Robert A. Vandorpe, M.D.; Qing Rui, M.B.; Vina M. Goghari, B.A.; Geoffrey N. Smith, Ph.D.; William G. Honer, M.D., F.R.C.P.C.
The American Journal of Psychiatry. 2006 November ; 11(163):2005-2007
PDFPDF
The American Journal of Psychiatry >
Article | November 01, 2006
Improvement in Social Competence With Short-Term Atypical Antipsychotic Treatment: A Randomized, Double-Blind Comparison of Quetiapine Versus Risperidone for Social Competence, Social Cognition, and Neuropsychological Functioning
Philip D. Harvey, Ph.D.; Thomas L. Patterson, Ph.D.; Larry S. Potter, M.S.; Kate Zhong, M.D.; Martin Brecher, M.D.
The American Journal of Psychiatry. 2006 November ; 11(163):1918-1925
PDFPDF
The American Journal of Psychiatry >
Treatment in Psychiatry | October 01, 2006
Medication-Induced Weight Gain and Dyslipidemia in Patients With Schizophrenia
Wayne S. Fenton, M.D.; Mark R. Chavez, Ph.D.
The American Journal of Psychiatry. 2006 October ; 10(163):1697-1704
PDFPDF  |  CME Activity (3)
The American Journal of Psychiatry >
Article | October 01, 2006
Hyperlipidemia Following Treatment With Antipsychotic Medications
Mark Olfson, M.D., M.P.H.; Steven C. Marcus, Ph.D.; Patricia Corey-Lisle, Ph.D., R.N.; A.V. Tuomari, M.S.; Patricia Hines, A.S.; Gilbert J. L’Italien, Ph.D.
The American Journal of Psychiatry. 2006 October ; 10(163):1821-1825
PDFPDF
The American Journal of Psychiatry >
Brief Report | October 01, 2006
Effect of 5-HT1A Receptor Gene Polymorphism on Negative and Depressive Symptom Response to Antipsychotic Treatment of Drug-Naive Psychotic Patients
Gavin P. Reynolds, Ph.D.; Belen Arranz, M.D., Ph.D.; Lucy A. Templeman, Ph.D.; Sofia Fertuzinhos, B.S.; Luis San, M.D., Ph.D.
The American Journal of Psychiatry. 2006 October ; 10(163):1826-1829
PDFPDF
FOCUS >
CLINICAL SYNTHESIS | September 01, 2006
Quick Reference for Psychopharmacology
FOCUS. 2006 September ; 4(4):480-483
PDFPDF
FOCUS >
INFLUENTIAL PUBLICATIONS | September 01, 2006
Bibliography Psychopharmacology
FOCUS. 2006 September ; 4(4):512-514
PDFPDF
FOCUS >
INFLUENTIAL PUBLICATIONS | September 01, 2006
The Search for New Off-Label Indications for Antidepressant, Antianxiety, Antipsychotic and Anticonvulsant Drugs
Guy Chouinard, M.D.
FOCUS. 2006 September ; 4(4):528-538
PDFPDF
FOCUS >
INFLUENTIAL PUBLICATIONS | September 01, 2006
Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients With Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic
T. Scott Stroup, M.D., M.P.H.; Jeffrey A. Lieberman, M.D.; Joseph P. McEvoy, M.D.; Marvin S. Swartz, M.D.; Sonia M. Davis, Dr.P.H.; Robert A. Rosenheck, M.D.; Diana O. Perkins, M.D., M.P.H.; Richard S.E. Keefe, Ph.D.; Clarence E. Davis, Ph.D.; Joanne Severe, M.S.; John K. Hsiao, M.D.
FOCUS. 2006 September ; 4(4):539-552
PDFPDF
FOCUS >
INFLUENTIAL PUBLICATIONS | September 01, 2006
Interpreting the Results of the CATIE Study
Jeffrey A. Lieberman, M.D.; John K. Hsiao, M.D.
FOCUS. 2006 September ; 4(4):564-564
PDFPDF
The Journal of Neuropsychiatry and Clinical Neurosciences >
CLINRESREPORT | September 01, 2006
A Pilot Study of Quetiapine Treatment of Aggression Due to Traumatic Brain Injury
Edward Kim, M.D., M.B.A.; Mona Bijlani, M.D.
The Journal of Neuropsychiatry and Clinical Neurosciences. 2006 September ; 4(18):547-549
PDFPDF
Psychiatric Services >
Other Article | August 01, 2006
Agreement Between Patients With Schizophrenia and Providers on Factors of Antipsychotic Medication Adherence
Jeffrey M. Pyne, M.D.; Jean McSweeney, Ph.D.; H. Scott Kane, M.D.; Susan Harvey, M.D.; Leslie Bragg, M.A.; Ellen Fischer, Ph.D.
Psychiatric Services. 2006 August ; 8(57):1170-1178
PDFPDF  |    Data Supplements
Psychiatric Services >
Special Section on CATIE Baseline Data | August 01, 2006
Special Section on CATIE Baseline Data: Baseline Use of Concomitant Psychotropic Medications to Treat Schizophrenia in the CATIE Trial
Miranda H. Chakos, M.D.; Ira D. Glick, M.D.; Alexander L. Miller, M.D.; Mark B. Hamner, M.D.; Del D. Miller, M.D.; Jayendra K. Patel, M.D.; Andre Tapp, M.D.; Richard S. E. Keefe, Ph.D.; Robert A. Rosenheck, M.D.
Psychiatric Services. 2006 August ; 8(57):1094-1101
PDFPDF
Psychiatric Services >
Taking Issue | August 01, 2006
What the CATIE Study Means for Clinical Practice
Jeffrey A. Lieberman, M.D.
Psychiatric Services. 2006 August ; 8(57):1075-1075
PDFPDF
Copyright ©
American
Psychiatric
Association